Search Results - "Fricot, A"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia by Willems, L, Chapuis, N, Puissant, A, Maciel, T T, Green, A S, Jacque, N, Vignon, C, Park, S, Guichard, S, Herault, O, Fricot, A, Hermine, O, Moura, I C, Auberger, P, Ifrah, N, Dreyfus, F, Bonnet, D, Lacombe, C, Mayeux, P, Bouscary, D, Tamburini, J

    Published in Leukemia (01-06-2012)
    “…The serine/threonine kinase mammalian target of rapamycin (mTOR) is crucial for cell growth and proliferation, and is constitutively activated in primary acute…”
    Get full text
    Journal Article
  2. 2

    Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling by Gabet, A-S, Coulon, S, Fricot, A, Vandekerckhove, J, Chang, Y, Ribeil, J-A, Lordier, L, Zermati, Y, Asnafi, V, Belaid, Z, Debili, N, Vainchenker, W, Varet, B, Hermine, O, Courtois, G

    Published in Cell death and differentiation (01-04-2011)
    “…Stem cell factor (SCF) and erythropoietin are strictly required for preventing apoptosis and stimulating proliferation, allowing the differentiation of…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9